ARTICLE | Clinical News
Heplisav: Phase III ongoing
July 27, 2015 7:00 AM UTC
Dynavax said an independent DSMB recommended for the third time continuation of the double-blind, U.S. Phase III HBV-23 trial comparing intramuscular Heplisav vs. Engerix-B based on safety data from a...